Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Melanoma research

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1097/CMR.0b013e3283107df7PMID 18971789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells.

  2008cited by this paper
• Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.

  2008cited by this paper
• Inhibitory effect of p-hydroxybenzyl alcohol on tyrosinase activity and melanogenesis.

  2007cited by this paper
• Melanoma inhibition by cyclooxygenase inhibitors

  2007cited by this paper
• Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples

  2006cited by this paper
• Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells.

  2006cited by this paper
• Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics

  2006cited by this paper
• Molecularly targeted therapy for melanoma

  2006cited by this paper
• Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells.

  2005cited by this paper
• Structural toxicity relationship of 4-alkoxyphenols' cytotoxicity towards murine B16-F0 melanoma cell line.

  2005cited by this paper
• Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).

  2005cited by this paper
• Histone deacetylase inhibitors and malignant melanoma.

  2005cited by this paper
• Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2.

  2004cited by this paper
• Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials.

  2004cited by this paper
• Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.

  2004cited by this paper
• Application of quantitative structure-toxicity relationships for the comparison of the cytotoxicity of 14 p-benzoquinone congeners in primary cultured rat hepatocytes versus PC12 cells.

  2004cited by this paper
• Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma

  2003cited by this paper
• Melatonin biological activity and binding sites in human melanoma cells

  2003cited by this paper
• Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes.

  2003cited by this paper
• Stress‐responsive JNK mitogen‐activated protein kinase mediates aspirin‐induced suppression of B16 melanoma cellular proliferation

  2003cited by this paper
• Metabolic activation of 4-hydroxyanisole by isolated rat hepatocytes.

  2002cited by this paper
• Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells

  2002cited by this paper
• Aspirin, other NSAIDs, and ovarian cancer risk (United States)

  2002cited by this paper
• Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.

  2002cited by this paper
• Expression of cyclooxygenase 2 in human malignant melanoma.

  2001cited by this paper
• Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women.

  2001cited by this paper
• A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

  2001cited by this paper
• Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II

  2001cited by this paper
• The Merck index : an encyclopedia of chemicals, drugs, and biologicals

  2001cited by this paper
• Comparison of in vitro cytotoxicity of N‐acetyl and N‐propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity

  2000cited by this paper
• Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells.

  2000cited by this paper
• Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

  1999cited by this paper
• Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts

  1999cited by this paper
• Gender differences in the activities of aspirin-esterases in rat tissues.

  1998cited by this paper
• Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system.

  1997cited by this paper
• Interaction of nitric oxide with 2-thio-5-nitrobenzoic acid: implications for the determination of free sulfhydryl groups by Ellman's reagent.

  1997cited by this paper
• Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas.

  1994cited by this paper
• Glutathione, ascorbate, and cellular protection.

  1994cited by this paper
• The Bradford method for protein quantitation.

  1994cited by this paper
• Coordinated mRNA and protein expression of human LAMP-1 in induction of melanogenesis after UV-B exposure and co-transfection of human tyrosinase and TRP-1 cDNAs.

  1994cited by this paper
• Glutathione depletion in mouse melanoma cells increases their sensitivity to oxidative lysis

  1992cited by this paper
• Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells

  1992cited by this paper
• Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells

  1992cited by this paper
• In vitro assessment of the structure – activity relationship of tyrosinase‐dependent cytotoxicity of a series of substituted phenols

  1991cited by this paper
• 1-bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes.

  1991cited by this paper
• Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols.

  1991cited by this paper
• A note on the inhibition of DT-diaphorase by dicoumarol.

  1991cited by this paper
• Cyclosporin A-sensitive and insensitive mechanisms produce the permeability transition in mitochondria.

  1989cited by this paper
• The bradford method for protein quantitation.

  1988cited by this paper
• Oxidative damage to DNA: relation to species metabolic rate and life span.

  1988cited by this paper
• Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.

  1988cited by this paper
• Two modes of analgesic action of aspirin, and the site of analgesic action of salicylic acid.

  1986cited by this paper
• Studies on the mechanism of action of quinone antitumor agents.

  1985cited by this paper
• Role of glutathione depletion in the cytotoxicity of acetaminophen in a primary culture system of rat hepatocytes.

  1985cited by this paper
• Increased microsomal oxidation of alcohols after pyrazole treatment and its similarities to the induction by ethanol consumption.

  1984cited by this paper
• Effect of acetaminophen (paracetamol) and its antagonists on glutathione (GSH) content in rat liver.

  1980cited by this paper
• Isolation of microsomal subfractions by use of density gradients.

  1978cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Acetylsalicylic acid and cancer: updates on the new potential of a nature-inspired drug

  2025cites this paper
• Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents.

  2024cites this paper
• Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review

  2024cites this paper
• Small-molecule redox modulators with anticancer activity: A comprehensive mechanistic update.

  2023cites this paper
• Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial.

  2022cites this paper
• In Vitro Effects of Selective COX and LOX Inhibitors and Their Combinations with Antineoplastic Drugs in the Mouse Melanoma Cell Line B16F10

  2021cites this paper
• Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines

  2020cites this paper
• Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways

  2020cites this paper
• Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention

  2019cites this paper
• Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials

  2018cites this paper
• Postdiagnosis aspirin use and overall survival in patients with melanoma

  2018cites this paper
• Targeted Prodrug Design for the Treatment of Malignant Melanoma

  2016cites this paper
• Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells

  2016cites this paper
• Use of Polyphenolic Compounds in Dermatologic Oncology

  2016cites this paper
• Aspirin in dermatology: Revisited

  2015cites this paper
• Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo

  2015cites this paper
• Aspirin use and melanoma: A UCLA pilot study.

  2015cites this paper
• Aspirin and Other NSAIDs as Chemoprevention Agents in Melanoma

  2014cites this paper
• Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice

  2014influential citation
• Critical role of STAT3 in melanoma metastasis through anoikis resistance

  2014cites this paper
• Aspirin use and melanoma risk: a review of the literature.

  2014cites this paper
• Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women

  2013cites this paper
• Effect of COX and LOX inhibitors on melanoma

  2012cites this paper
• Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.

  2012cites this paper
• Efficacy of Caffeic Acid Phenethyl Ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice

  2011cites this paper
• Efecto tóxico de los extractos acuosos de pinus caribaea y halimeda monile en células humanas. Cytotoxic effect of pinus caribaea and halimeda monile aqueous extracts in human cells.

  2010cites this paper
• Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines.

  2010cites this paper
• Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.

  2010cites this paper
• NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates

  2010cites this paper
• Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.

  2009cites this paper
• Antioxidative characteristics and inhibition of α‐melanocyte‐stimulating hormone‐stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare

  2009cites this paper
• Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities

  2009cites this paper